Pancreatic cancer survival is a race against time, yet the current standard of care is failing. Surgery remains the only cure, but it is only possible when the disease is caught early. Today, nearly 85% of cases are diagnosed too late for life-saving intervention because traditional imaging misses 40% of small tumors. We exist to change this equation.

 

Our mission is to redefine the global standard of care by accelerating AI-driven early detection. We bridge the gap between breakthrough research and real-world application by raising dedicated funds for pioneering researchers developing artificial intelligence approaches to scan analysis. Our funding moves AI from the lab into the clinic, empowering radiologists with powerful tools that identify tumors at their most curable stage.

 

Beyond the technology, we are a voice for systemic change. We lead policy advocacy to ensure that as AI-enhanced scans prove their accuracy, they become accessible to all. We are working to shift insurance coverage policies so that advanced CT screening becomes a recognized, covered preventive standard. By combining cutting-edge innovation with aggressive advocacy, we give patients more than just a diagnosis—we give them a real chance at survival.